Evidence map›Paper›PMID 26731301›Full record

ArticleScientific data2016

Comprehensive systems biology analysis of a 7-month cigarette smoke inhalation study in C57BL/6 mice.

Sam Ansari, Karine Baumer, Stéphanie Boué, Sophie Dijon, Remi Dulize, Kim Ekroos, Ashraf Elamin, Clement Foong, Emmanuel Guedj, Julia Hoeng and 17 more

Abstract readDataset
In one paragraph

Article in Scientific data, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Sam AnsariPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Karine BaumerPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Stéphanie BouéPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Sophie DijonPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Remi DulizePhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Kim EkroosZora Biosciences Oy, Biologinkuja 1, Espoo 02150, Finland.
Ashraf ElaminPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Clement FoongPhilip Morris International Research Laboratories, 50 Science Park Road, Science Park II, Singapore, Singapore 117406.
Emmanuel GuedjPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Julia HoengPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Nikolai V IvanovPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Subash KrishnanPhilip Morris International Research Laboratories, 50 Science Park Road, Science Park II, Singapore, Singapore 117406.
Patrice LeroyPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Florian MartinPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Celine MergPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Michael J PeckPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Manuel C PeitschPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Blaine PhillipsPhilip Morris International Research Laboratories, 50 Science Park Road, Science Park II, Singapore, Singapore 117406.
Walter K SchlageBiology consultant, Max-Baermann-Str. 21, 51429 Bergisch Gladbach, Germany.
Thomas SchneiderPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Marja TalikkaPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Bjoern TitzPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Patrick VanscheeuwijckPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Emilija VeljkovicPhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Terhi VihervaaraZora Biosciences Oy, Biologinkuja 1, Espoo 02150, Finland.
Gregory VuillaumePhilip Morris International R&D, Philip Morris Products S. A., Quai Jeanrenaud 5, Neuchâtel 2000, Switzerland.
Ching Qing WoonPhilip Morris International Research Laboratories, 50 Science Park Road, Science Park II, Singapore, Singapore 117406.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Smoking of combustible cigarettes has a major impact on human health. Using a systems toxicology approach in a model of chronic obstructive pulmonary disease (C57BL/6 mice), we assessed the health consequences in mice of an aerosol derived from a prototype modified risk tobacco product (pMRTP) as compared to conventional cigarettes. We investigated physiological and histological endpoints in parallel with transcriptomics, lipidomics, and proteomics profiles in mice exposed to a reference cigarette (3R4F) smoke or a pMRTP aerosol for up to 7 months. We also included a cessation group and a switching-to-pMRTP group (after 2 months of 3R4F exposure) in addition to the control (fresh air-exposed) group, to understand the potential risk reduction of switching to pMRTP compared with continuous 3R4F exposure and cessation. The present manuscript describes the study design, setup, and implementation, as well as the generation, processing, and quality control analysis of the toxicology and 'omics' datasets that are accessible in public repositories for further analyses.

Indexed as

Pulmonary Disease, Chronic ObstructiveAnimalsBody WeightFemaleLipid MetabolismLungMiceMice, Inbred C57BLProtein Array AnalysisProteomicsSmoke Inhalation InjurySmoking

Identifiers

PMID26731301
PMCPMC4700839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.